A coalition of 156 countries has agreed a “landmark” deal to enable the rapid and equitable global distribution of any new coronavirus vaccines to 3% of participating countries’ populations, to protect vulnerable healthcare systems, frontline health workers and those in social care settings .
The Covid-19 vaccine allocation plan – co-led by the World Health Organisation and known as Covax – has been set up to ensure that the research, purchase and distribution of any new vaccine is shared equally between the world’s richest countries and those in the developing world.
Sixty-four higher income economies have already joined Covax, which includes commitments from 35 economies as well as the European commission, which will procure doses on behalf of the 27 European Union member states plus Norway and Iceland with 38 more expected to join in the coming days.
Ultimately the scheme aims to deliver 2 bllion doses of safe, effective vaccines around the world by the end of 2021.
Recognising that the first useful vaccines to emerge may be in short
supply, approved vaccines will initially be made available to a tightly
targeted 3% of the population of participating countries, building over
time to 20% of each country’s most vulnerable population .
No comments:
Post a Comment